START Dallas-Fort Worth

Fort Worth, Texas 76104

8 studies enrolling now · 8 studies all time

What they study most

Adenocarcinoma of Esophagus, Advanced Breast Cancer, Advanced Ovarian Cancer, Advanced Solid Tumor, Advanced Unresectable Hepatocellular Carcinoma, Biliary Tract Carcinoma, Bladder Cancer, Breast Cancer, Colorectal Cancer, Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Cancer (GC)

Studies at this site

• A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer — Recruiting now
• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors — Recruiting now
• A Study in Patients With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
• A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors — Recruiting now
• First In Human Study of CX-2051 in Advanced Solid Tumors — Recruiting now
• A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors — Recruiting now
• IKS014 in Advanced Solid Tumors That Express HER2 — Recruiting now
• Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma — Recruiting now